Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation

Por Runkle, Kristin B., Meyerkord, Cheryl L., Desai, Neelam V., Takahashi, Yoshinori, Wang, Hong-Gang
Publicado em 2012

Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression

Por Alkhasawneh, Ahmad, Duckworth, Lizette Vila, George, Thomas J., Desai, Neelam V., Sommerfeld, Alex J., Lu, Xiaomin, Toro, Tania Zuluaga
Publicado no J Gastrointest Oncol (2016)

Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

Por Desai, Neelam V, Sliesoraitis, Sarunas, Hughes, Steven J, Trevino, Jose G, Zlotecki, Robert A, Ivey, Alison M, George, Thomas J
Publicado no Cancer Med (2015)

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

Por Desai, Neelam V., Torous, Vanda, Parker, Joel, Auman, James T., Rosson, Gary B., Cruz, Cassandra, Perou, Charles M., Schnitt, Stuart J., Tung, Nadine
Publicado no Breast Cancer Res (2018)

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: lack of response to EGFR inhibitors

Por Le, Xiuning, Desai, Neelam V., Majid, Adnan, Karp, Rebecca S., Huberman, Mark S., Rangachari, Deepa, Kent, Michael S., Gangadharan, Sidharta P., Folch, Erik, VanderLaan, Paul A., Costa, Daniel B.
Publicado no Lung Cancer (2015)